Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance

Urological Research

Volumn 28, Issue 2, 2000, Pages 86-92

  Yu, Dah Shyong ^a   Ma, Cheng Ping ^a   Chang, Sun Yran ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Glutathione transferase; MDR related protein; Multidrug resistance; P Glycoprotein; Renal cell carcinoma; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL MEMBRANE; CYTOPLASM; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; HUMANS; KIDNEY NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED;

EID: 0034125751     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050143     Document Type: Article

References (32)

1. Beck J, Nietheammer D, Gekeler V (1994) High mdr1-and mrp-, but low topoisomerase I α-gene expression in B-cell chronic lymphocytic leukemia. Cancer Lett 86: 135
2. Benson MC, Giella J, Whang IS, Buttyan R, Hensle TW, Karp F, Olsson CA (1991) Flow cytometric determination of the multidrug resistance phenotype in transitional cell cancer of the bladder: implications and applications. J Urol 146: 982
3. Binaschi M, Supino R, Gambetta RA, Giaccone G, Prosperi E, Capranico G, Cataldo I, Zunino F (1995) MRP gene overexpression in a human doxorubicin-resistant SCLC ceil line: alternations in cellular pharmacokinetics and in pattern of cross-resistance. Int J Cancer 62: 84
4. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Michell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936
5. Chin K-V, Ueda K, Gottesman MM (1992) Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255: 459
6. Fojo A, Akiyama S, Gottesman MM, Pastan I (1985) Reduced drug accumulation in multiple drug resistant human KB carcinoma. Cancer Res 45: 3002
7. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263: 1263
8. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG (1994) Overexpression of multidrug resistance-associate protein (MRP) increases resistance to natural product drugs. Cancer Res 54: 357
9. Krishnamachary N, Center MS (1993) The MRP gene associated with a non-p-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res 53: 3658
10. Ling V, Thompson L (1974) Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83: 103
11. Loken MR, Sweet RG, Herzenberg LA (1976) Cell discrimination by multiangle light scattering. J Histochem Cytochem 24: 284
12. Long JP, Prout GR, Wong YK, Lin CW (1990) The effect of verapamil on a multidrug resistant bladder carcinoma cell line and its potential as an intravesical chemotherapeutic agent. J Urol 143: 1053
13. Marx JL (1989) Drug resistance of cancer cell probed. Science 234: 818
14. Matsuo K, Kohno K, Takano H, Sato S, Kine A. Kuwano M (1990) Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines. Cancer Res 50: 5819
15. McGovern F, Kachel T, Vijan S, Lin C-W, Prout GR Jr (1988) Establishment and characterization of a doxorubicin-resistant human bladder cancer cell line (MGH-UIR). J Urol 140: 410
16. Mickisch G, Bier H, Bergler W, Bak M, Tschada R, Alken P (1990) P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas. Urol Int 45: 1470
17. Mickisch GH, Kossig J, Keilhauer G, Schlick E, Tschada RK, Alken PM (1990) Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 50: 3670
18. Mickisch GH, Roehrich K, Koessig J, Forster S, Tschada RK, Alken PM (1990) Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol 144: 755
19. Mickisch GH, Merlino GT, Alken PM, Gottesman MM, Pastan I (1991) New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human mdr1 gene. J Urol 146: 447
20. Mickisch GH, Kossig J, Tschada RK, Keilhauer G, Schlick E, Alken PM (1991) Circumvention of multidrug resistance mediated by p-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma. Urol Int 47: 118
21. Mickisch GH, Alken PM (1992) Modulation of multidrug resistance in human renal cell carcinomas. In: Staehler G. Pomer S (eds) Basic and clinical research on renal cell carcinoma. Springer, Berlin Heidelberg New York, pp 79
22. Mickisch G, Bier H, Tschada R, Alkein P (1992) Effects of buthionine sulfoximine mediated glutathione depletion in chemoresistant human renal cell carcinomas. In: Jocham D, Thuroff JW, Rubben H (eds) Invest. Urol. 4, Springer, Berlin Heidelberg New York, pp 21
23. Moscow JA, Cowan KH (1988) Multidrug resistance. J Natl Cancer Inst 80: 14
24. Myers TW, Gelfand DH (1991) Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 30: 7661
25. Novotny MV, Cobb KA, Liu JP (1990) Recent advances in capillary electrophoresis of proteins, peptides and amino acids. Electrophoresis 11: 735
26. Pastan I, Gottesman MM (1987) Multiple drug resistance in human cancer. N Engl J Med 316: 1388
27. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH (1994) Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity to topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152
28. Vugrin D (1987) Systemic therapy of metastatic renal cell carcinoma. Semin Nephrol 7: 152
29. Yu DS, Hsu CM, Lee WH, Chang SY, Ma CP (1993) Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and clinical behavior. J Surg Res 55: 480
30. Yu DS, Chang SY, Ma CP (1993) The effect of methylene blue-sensitized photodynamic treatment on bladder cancer cells: a further study on flow cytometric basis. J Urol 149: 1198
31. Yu DS, Chang SY, Ma CP (1997) The correlation of membranous glycoprotein-gp-170, cytoplasmic glutathione and glucose-6-phosphate dehydrogenase levels with multidrug resistance in transitional cell carcinoma cell lines of the urinary tract. J Urol 157: 727
32. Yu DS, Chang SY, Ma CP (1998) Characterization and modulation of transitional cell carcinoma cell lines with acquired multidrug resistance. Br J Urol 81: 234